Home Applications 208599 Application 208599
Type ANDA
Sponsor PRINSTON PHARMA INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TICAGRELOR TICAGRELOR TABLET;ORAL 60MG No No 002 TICAGRELOR TICAGRELOR TABLET;ORAL 90MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208599-001 TICAGRELOR TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A208599-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 d06236e962d9…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208599-001 TICAGRELOR 90MG TABLET / ORAL AB 2024-08-16 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join TICAGRELOR TICAGRELOR Solco Healthcare U.S., LLC 5be5ef20-fc9f-4c3b-a482-83ffd8a3ab47 2025-11-11 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 208599 application number: ANDA208599
Documents# Document, Submission type, Date table Document Submission type Date 56854 ORIG 2018-12-20